|Bid||35.88 x 800|
|Ask||36.00 x 800|
|Day's Range||32.56 - 36.12|
|52 Week Range||29.74 - 394.20|
|PE Ratio (TTM)||N/A|
|YTD Daily Total Return||-70.27%|
|Beta (5Y Monthly)||-8.22|
|Expense Ratio (net)||1.65%|
In this episode of Influencers, Eli Lilly Chairman & CEO David Ricks joins Andy to discuss the latest in the pharmaceutical industry, new progress in the fight against COVID-19, and potential groundbreaking advancements for the treatment of Alzheimer’s.
Eli Lilly CEO David Ricks joins 'Influencers with Andy Serwer' to discuss progress in the fight against COVID-19.
Eli Lilly CEO David Ricks joins 'Influencers with Andy Serwer' to discuss the FDA's approval of Biogen's new Alzheimer’s drug.